Affimed (AFMD) Stock Forecast, Price Target & Predictions
AFMD Stock Forecast
Affimed stock forecast is as follows: an average price target of $7.50 (represents a 184.09% upside from AFMD’s last price of $2.64) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
AFMD Price Target
AFMD Analyst Ratings
Buy
Affimed Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Apr 01, 2024 | Bradley Canino | Stifel Nicolaus | $5.00 | $5.30 | -5.66% | 89.39% |
Apr 01, 2024 | Swayampakula Ramakanth | H.C. Wainwright | $10.00 | $5.30 | 88.68% | 278.79% |
10
Affimed Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $7.50 |
Last Closing Price | $2.64 | $2.64 | $2.64 |
Upside/Downside | -100.00% | -100.00% | 184.09% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 12, 2024 | Laidlaw | Buy | Buy | Hold |
Apr 01, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Dec 12, 2022 | H.C. Wainwright | - | Buy | Initialise |
Oct 11, 2022 | Stifel Nicolaus | - | Positive | Downgrade |
Mar 31, 2022 | Piper Sandler | - | Overweight | Initialise |
Feb 23, 2022 | Cantor Fitzgerald | - | Overweight | Initialise |
10
Affimed Financial Forecast
Affimed Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.51M | $11.16M | $14.89M | $7.30M | $8.01M | $10.34M | $8.66M | $9.71M | $11.66M | $9.75M | $10.54M | $2.93M | $5.13M | $3.93M | $2.10M |
Avg Forecast | $151.48K | $151.73K | $151.98K | $152.23K | $353.26K | $423.91K | $423.91K | $1.45M | $1.08M | $1.67M | $1.16M | $458.57K | $1.66M | $1.93M | $4.65M | $6.16M | $6.92M | $6.29M | $8.83M | $10.31M | $8.98M | $9.59M | $9.01M | $10.63M | $16.63M | $8.79M | $5.20M | $5.47M | $3.09M | $3.71M |
High Forecast | $267.66K | $268.10K | $268.54K | $268.99K | $624.20K | $749.04K | $749.04K | $3.29M | $1.46M | $2.95M | $2.05M | $810.29K | $2.62M | $3.41M | $8.22M | $10.89M | $12.23M | $6.29M | $8.83M | $10.31M | $8.98M | $9.59M | $9.01M | $10.63M | $16.63M | $8.79M | $5.20M | $5.47M | $3.09M | $3.71M |
Low Forecast | $78.10K | $78.23K | $78.36K | $78.49K | $182.14K | $218.57K | $218.57K | $529.89K | $688.00K | $861.13K | $597.58K | $236.45K | $643.08K | $995.10K | $2.40M | $3.18M | $3.57M | $6.29M | $8.83M | $10.31M | $8.98M | $9.59M | $9.01M | $10.63M | $16.63M | $8.79M | $5.20M | $5.47M | $3.09M | $3.71M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 11 | 8 | 8 | 12 | 7 | 12 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.73% | 1.61% | 2.37% | 0.83% | 0.78% | 1.15% | 0.90% | 1.08% | 1.10% | 0.59% | 1.20% | 0.56% | 0.94% | 1.27% | 0.57% |
Forecast
Affimed EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 11 | 8 | 8 | 12 | 7 | 12 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-30.66M | $-27.85M | $-18.73M | $-21.33M | $-16.85M | $-22.51M | $-16.56M | $-18.24M | $1.83M | $-14.66M | $-5.65M | $-11.90M | $-7.95M | $-12.64M | $-10.55M |
Avg Forecast | $-151.48K | $-151.73K | $-151.98K | $-152.23K | $-353.26K | $-423.91K | $-423.91K | $-1.45M | $-1.08M | $-1.67M | $-1.16M | $-458.57K | $-1.66M | $-1.93M | $-4.65M | $-6.16M | $-6.92M | $-6.29M | $-8.83M | $-10.31M | $-8.98M | $-9.59M | $-9.01M | $3.71M | $-16.63M | $-8.79M | $-5.20M | $-7.95M | $-3.09M | $-3.71M |
High Forecast | $-78.10K | $-78.23K | $-78.36K | $-78.49K | $-182.14K | $-218.57K | $-218.57K | $-529.89K | $-688.00K | $-861.13K | $-597.58K | $-236.45K | $-643.08K | $-995.10K | $-2.40M | $-3.18M | $-3.57M | $-6.29M | $-8.83M | $-10.31M | $-8.98M | $-9.59M | $-9.01M | $4.45M | $-16.63M | $-8.79M | $-5.20M | $-6.36M | $-3.09M | $-3.71M |
Low Forecast | $-267.66K | $-268.10K | $-268.54K | $-268.99K | $-624.20K | $-749.04K | $-749.04K | $-3.29M | $-1.46M | $-2.95M | $-2.05M | $-810.29K | $-2.62M | $-3.41M | $-8.22M | $-10.89M | $-12.23M | $-6.29M | $-8.83M | $-10.31M | $-8.98M | $-9.59M | $-9.01M | $2.96M | $-16.63M | $-8.79M | $-5.20M | $-9.53M | $-3.09M | $-3.71M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.97% | 4.03% | 2.98% | 2.42% | 1.63% | 2.51% | 1.73% | 2.02% | 0.49% | 0.88% | 0.64% | 2.29% | 1.00% | 4.09% | 2.85% |
Forecast
Affimed Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 11 | 8 | 8 | 12 | 7 | 12 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-31.98M | $-36.73M | $-13.77M | $-17.16M | $-16.66M | $-23.27M | $-17.09M | $-18.75M | $1.41M | $-14.87M | $-5.97M | $-12.24M | $-8.29M | $-12.99M | $-10.88M |
Avg Forecast | $-10.15M | $-10.17M | $-8.74M | $-8.76M | $-9.08M | $-8.90M | $-8.28M | $-8.21M | $-10.26M | $-14.08M | $-14.80M | $-23.76M | $-23.64M | $-28.26M | $-28.60M | $-29.22M | $-29.11M | $-26.55M | $-25.57M | $-26.95M | $-24.51M | $-21.42M | $-13.11M | $2.86M | $-2.27M | $-12.58M | $-20.23M | $-8.29M | $-27.32M | $-27.44M |
High Forecast | $-3.76M | $-3.77M | $-3.24M | $-3.25M | $-3.36M | $-3.29M | $-3.07M | $-7.58M | $-5.93M | $-5.21M | $-5.48M | $-8.80M | $-17.84M | $-10.46M | $-10.59M | $-10.82M | $-10.78M | $-26.55M | $-25.57M | $-26.95M | $-24.51M | $-21.42M | $-13.11M | $3.43M | $-2.27M | $-12.58M | $-20.23M | $-6.63M | $-27.32M | $-27.44M |
Low Forecast | $-20.27M | $-20.32M | $-17.46M | $-17.50M | $-18.14M | $-17.77M | $-16.54M | $-8.84M | $-15.76M | $-28.12M | $-29.55M | $-47.45M | $-30.63M | $-56.44M | $-57.11M | $-58.35M | $-58.14M | $-26.55M | $-25.57M | $-26.95M | $-24.51M | $-21.42M | $-13.11M | $2.29M | $-2.27M | $-12.58M | $-20.23M | $-9.95M | $-27.32M | $-27.44M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.26% | 0.52% | 0.67% | 0.62% | 0.95% | 0.80% | 1.43% | 0.49% | 6.54% | 0.47% | 0.61% | 1.00% | 0.48% | 0.40% |
Forecast
Affimed SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 11 | 8 | 8 | 12 | 7 | 12 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $6.85M | $8.57M | $8.09M | $8.37M | $7.04M | $7.45M | $6.84M | $5.44M | $4.49M | $4.13M | $3.46M | $2.61M | $3.52M | $2.70M | $2.79M |
Avg Forecast | $161.20K | $161.47K | $161.74K | $162.00K | $375.93K | $451.12K | $451.12K | $1.54M | $1.15M | $1.78M | $1.23M | $488.01K | $1.76M | $2.05M | $4.95M | $6.56M | $7.36M | $6.70M | $9.39M | $10.97M | $9.56M | $10.21M | $9.59M | $9.08M | $17.69M | $9.36M | $5.54M | $3.52M | $3.29M | $3.94M |
High Forecast | $284.84K | $285.31K | $285.78K | $286.25K | $664.26K | $797.12K | $797.12K | $3.50M | $1.55M | $3.14M | $2.18M | $862.30K | $2.79M | $3.63M | $8.75M | $11.59M | $13.01M | $6.70M | $9.39M | $10.97M | $9.56M | $10.21M | $9.59M | $10.90M | $17.69M | $9.36M | $5.54M | $4.23M | $3.29M | $3.94M |
Low Forecast | $83.12K | $83.25K | $83.39K | $83.53K | $193.84K | $232.60K | $232.60K | $563.90K | $732.17K | $916.41K | $635.94K | $251.62K | $684.36K | $1.06M | $2.55M | $3.38M | $3.80M | $6.70M | $9.39M | $10.97M | $9.56M | $10.21M | $9.59M | $7.27M | $17.69M | $9.36M | $5.54M | $2.82M | $3.29M | $3.94M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.16% | 1.21% | 0.89% | 0.64% | 0.78% | 0.67% | 0.57% | 0.49% | 0.23% | 0.37% | 0.47% | 1.00% | 0.82% | 0.71% |
Forecast
Affimed EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 11 | 8 | 8 | 12 | 7 | 12 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.21 | $-0.26 | $-0.09 | $-0.12 | $-0.14 | $-0.29 | $-0.14 | $-0.16 | $0.01 | $-0.13 | $-0.07 | $-0.16 | $-0.11 | $-0.17 | $-0.17 |
Avg Forecast | $-0.66 | $-0.66 | $-0.57 | $-0.57 | $-0.59 | $-0.58 | $-0.54 | $-0.54 | $-0.67 | $-0.92 | $-0.97 | $-1.55 | $-1.55 | $-1.85 | $-1.87 | $-1.91 | $-1.90 | $-1.74 | $-1.67 | $-1.76 | $-1.60 | $-1.40 | $-0.86 | $-1.00 | $-0.15 | $-0.82 | $-1.32 | $-1.29 | $-1.79 | $-1.79 |
High Forecast | $-0.25 | $-0.25 | $-0.21 | $-0.21 | $-0.22 | $-0.22 | $-0.20 | $-0.50 | $-0.39 | $-0.34 | $-0.36 | $-0.58 | $-1.17 | $-0.68 | $-0.69 | $-0.71 | $-0.70 | $-1.74 | $-1.67 | $-1.76 | $-1.60 | $-1.40 | $-0.86 | $-1.00 | $-0.15 | $-0.82 | $-1.32 | $-1.29 | $-1.79 | $-1.79 |
Low Forecast | $-1.32 | $-1.33 | $-1.14 | $-1.14 | $-1.19 | $-1.16 | $-1.08 | $-0.58 | $-1.03 | $-1.84 | $-1.93 | $-3.10 | $-2.00 | $-3.69 | $-3.73 | $-3.81 | $-3.80 | $-1.74 | $-1.67 | $-1.76 | $-1.60 | $-1.40 | $-0.86 | $-1.00 | $-0.15 | $-0.82 | $-1.32 | $-1.29 | $-1.79 | $-1.79 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.11% | 0.14% | 0.05% | 0.07% | 0.08% | 0.18% | 0.10% | 0.19% | -0.01% | 0.86% | 0.09% | 0.12% | 0.09% | 0.10% | 0.09% |
Forecast
Affimed Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
HEPA | Hepion Pharmaceuticals | $0.69 | $70.00 | 10044.93% | Buy |
ELEV | Elevation Oncology | $0.61 | $9.00 | 1375.41% | Buy |
XFOR | X4 Pharmaceuticals | $0.37 | $3.67 | 891.89% | Buy |
INZY | Inozyme Pharma | $2.69 | $14.67 | 445.35% | Buy |
ADCT | ADC Therapeutics SA | $1.94 | $9.33 | 380.93% | Buy |
ADAP | Adaptimmune Therapeutics | $0.64 | $2.83 | 342.19% | Buy |
PDSB | PDS Bio | $2.20 | $9.00 | 309.09% | Buy |
DAWN | Day One Biopharmaceuticals | $13.34 | $38.80 | 190.85% | Buy |
AFMD | Affimed | $2.64 | $7.50 | 184.09% | Buy |
AGEN | Agenus | $2.86 | $8.00 | 179.72% | Hold |
TERN | Terns Pharmaceuticals | $5.71 | $14.25 | 149.56% | Buy |
LPTX | Leap Therapeutics | $2.58 | $5.50 | 113.18% | Buy |
MREO | Mereo BioPharma Group | $3.68 | $6.75 | 83.42% | Buy |
CRVS | Corvus Pharmaceuticals | $8.94 | $10.67 | 19.35% | Buy |
EFTR | eFFECTOR Therapeutics | - | $5.50 | - | Buy |